{"created":"2023-07-27T06:29:35.328373+00:00","id":14366,"links":{},"metadata":{"_buckets":{"deposit":"810f2700-a088-4723-a1a8-9fd33ff81096"},"_deposit":{"created_by":3,"id":"14366","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"14366"},"status":"published"},"_oai":{"id":"oai:kanazawa-u.repo.nii.ac.jp:00014366","sets":["1132:1133:1134"]},"author_link":["539"],"item_11_biblio_info_8":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017-02-22","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"(Editors: Tsugikazu Komoda)","bibliographicPageStart":"25p.","bibliographicVolumeNumber":"Jan 7, 2016","bibliographic_titles":[{"bibliographic_title":"The HDL handbook 3rd Edition: Biological Functions and Clinical Implications"}]}]},"item_11_description_21":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Although some CETP-lowering SNPs in the CETP gene are variably associated with improved clinical outcomes in patients with coronary artery disease (CAD), three low molecular weight oral CETP inhibitors (torcetrapib, dalcetrapib, and evacetrapib) have not shown any clinical benefits despite remarkable increases in HDL-cholesterol levels ranging 31-138%. Potential causes for that failure are discussed in terms of off-target effects of some inhibitors, potential misleading interpretation of genetic epidemiological surveys in CETP gene, and inadequate alteration in HDL function induced by the inhibitors. Possible modalities of CETP inhibition such as antisense nucleotides and monoclonal antibodies are discussed.","subitem_description_type":"Abstract"}]},"item_11_description_22":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"A part of the book","subitem_description_type":"Other"}]},"item_11_publisher_17":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Academic Press / Elsevier"}]},"item_11_relation_10":{"attribute_name":"ISBN","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"9780128125137","subitem_relation_type_select":"ISBN"}}]},"item_11_relation_28":{"attribute_name":"関連URI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://www.elsevier.com/books/the-hdl-handbook/komoda/978-0-12-812513-7","subitem_relation_type_select":"URI"}}]},"item_11_rights_23":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"© Academic Press 2017"}]},"item_11_version_type_25":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Inazu, Akihiro"}],"nameIdentifiers":[{},{},{},{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-10-03"}],"displaytype":"detail","filename":"ME-PR-INAZU-A-2017.pdf","filesize":[{"value":"201.6 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"ME-PR-INAZU-A-2017.pdf","url":"https://kanazawa-u.repo.nii.ac.jp/record/14366/files/ME-PR-INAZU-A-2017.pdf"},"version_id":"4677c22a-85bd-49ee-a452-5ee615806746"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"book","resourceuri":"http://purl.org/coar/resource_type/c_2f33"}]},"item_title":"CETP deficiency and concerns in CETP inhibitor development","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"CETP deficiency and concerns in CETP inhibitor development"}]},"item_type_id":"11","owner":"3","path":["1134"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-10-03"},"publish_date":"2017-10-03","publish_status":"0","recid":"14366","relation_version_is_last":true,"title":["CETP deficiency and concerns in CETP inhibitor development"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-07-28T00:48:28.511271+00:00"}